Skip to main navigation Skip to search Skip to main content

Neurobiological Pathways Between Chronic Stress and Depression: Dysregulated Adaptive Mechanisms?

Research output: Contribution to journalArticlepeer-review

Abstract

Stress-related diseases have been predicted to become major contributors to the Global Disease Burden within the next 20 years. Of these, depression is one of the principal identifiable sources of concern for public mental health, and has been hypothesized to be an outcome of prolonged stress. Examination of the hyper-responsiveness of the Hypothalamic-Pituitary-Adrenal axis, consequent elevated serum cortisol, plus the effects of this upon brain structure and function, provides a model for understanding how chronic stress may be a causal vector in the development of depression. Evidence from studies of the effectiveness of antidepressants aimed at reducing cortisol within depressed patients supports this model and suggests avenues for future research and treatment of stress-induced depression.
Original languageEnglish
Pages (from-to)33-45
JournalClinical Medicine: Psychiatry
Volume2
Publication statusPublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Psychiatry (incl Psychotherapy)

Fingerprint

Dive into the research topics of 'Neurobiological Pathways Between Chronic Stress and Depression: Dysregulated Adaptive Mechanisms?'. Together they form a unique fingerprint.

Cite this